PTMScan® Methyl Histidine Motif (me-H) Kit #68811
Additional Information
This product is intended for peptide enrichment and mass spectrometry analysis. To learn more about our Proteomics Kits and Services please answer a few questions for our Proteomics group.
Product Information
Storage
Antibody beads supplied in IAP buffer containing 50% glycerol. Store at -20°C. Do not aliquot the antibody.
实验步骤
Product Description
PTMScan® Technology employs a proprietary methodology from Cell Signaling Technology (CST) for peptide enrichment by immunoprecipitation using a specific bead-conjugated antibody in conjunction with liquid chromatography (LC) tandem mass spectrometry (MS/MS) for quantitative profiling of post-translational modification (PTM) sites in cellular proteins. These include phosphorylation, ubiquitination, acetylation, and methylation, among others. PTMScan® Technology enables researchers to isolate, identify, and quantitate large numbers of post-translationally modified cellular peptides with a high degree of specificity and sensitivity, providing a global overview of PTMs in cell and tissue samples without preconceived biases about where these modified sites occur. For more information on PTMScan® products and services, please visit Proteomics Resource Center.
Background
Histidine methylation (me-H) is a naturally occurring post-translational modification (PTM) that occurs on the imidazole ring of the histidine side chain. There are two isomers of histidine methylation: 1-methyl- (1mH) and 3-methyl-histidine (3mH), differing in which of the two nitrogens on the imidazole ring is methylated. According to IUPAC nomenclature, the nitrogen adjacent to the side chain is labeled as the "π" or "3" position, while the nitrogen atom farthest from the side chain is labeled as the "τ" or "1" position (1). Thus, IUPAC and most chemical suppliers refer to methylation on those nitrogen atoms as 3mH and 1mH, respectively. However, many biochemical papers reverse the numerical assignment of the nitrogens.
Early studies identified actin and myosin, isolated from skeletal muscle, as protein substrates containing me-H (2). Due to the abundance of this PTM in muscle tissue, the measurement of free me-H excreted in urine has been proposed as a biomarker of muscle breakdown and turnover (3,4). Additional non-cytoskeletal substrates include histones (5) and the large ribosomal subunit protein (6,7). Both the human and Saccharomyces cerevisiae homologs of the large ribosomal subunit protein contain a conserved histidine residue (RPL3 H245 and Rpl3 H243, respectively) that is methylated by METTL18 and Hpm1, respectively. Methylation on the histidine residue blocks hydrogen bond formation with the 28S rRNA subunit, which may affect overall ribosomal structure and translation efficiency.
Despite the identification of me-H sites on some abundant proteins, such as actin, proteomics studies estimate that the number of histidine methylation sites is less than the number of lysine or arginine methylation sites (8). The elucidation of me-H sites, as well as the enzymes that regulate this PTM, remain an area of active research (9).
Early studies identified actin and myosin, isolated from skeletal muscle, as protein substrates containing me-H (2). Due to the abundance of this PTM in muscle tissue, the measurement of free me-H excreted in urine has been proposed as a biomarker of muscle breakdown and turnover (3,4). Additional non-cytoskeletal substrates include histones (5) and the large ribosomal subunit protein (6,7). Both the human and Saccharomyces cerevisiae homologs of the large ribosomal subunit protein contain a conserved histidine residue (RPL3 H245 and Rpl3 H243, respectively) that is methylated by METTL18 and Hpm1, respectively. Methylation on the histidine residue blocks hydrogen bond formation with the 28S rRNA subunit, which may affect overall ribosomal structure and translation efficiency.
Despite the identification of me-H sites on some abundant proteins, such as actin, proteomics studies estimate that the number of histidine methylation sites is less than the number of lysine or arginine methylation sites (8). The elucidation of me-H sites, as well as the enzymes that regulate this PTM, remain an area of active research (9).
- (1984) Biochem J 219, 345-73.
- Johnson, P. et al. (1967) Biochem J 105, 361-70.
- Long, C.L. et al. (1975) Metabolism 24, 929-35.
- Bilmazes, C. et al. (1978) Metabolism 27, 525-30.
- Hayashi, T. et al. (2023) J Biol Chem 299, 105131.
- Al-Hadid, Q. et al. (2014) Mol Cell Biol 34, 2903-16.
- Matsuura-Suzuki, E. et al. (2022) Elife 11, e72780. doi: 10.7554/eLife.72780.
- Kapell, S. and Jakobsson, M.E. (2021) NAR Genom Bioinform 3, lqab045.
- Wang, X. et al. (2023) Cell Discov 9, 38.
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意，否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件，除非书 CST 的合法授书代表以书面形式书独接受， 否书均被拒书，并且无效。
专品专有“专供研究使用”的专专或专似的专专声明， 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的， 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专，且专用于研专用途。将专品用于专断、专防或治专目的， 或专专售（专独或作专专成）或其他商专目的而专专专品，均需要 CST 的专独专可。客专：(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品，或使用专品制造任何商专专品，(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专，或使用专品开专任何与 CST 的专品或服专专争的专品或服专， (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专，(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品， (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专
For Research Use Only. Not for Use in Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
PTMScan is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our
Trademark Information page.